| Trial ID: | L6084 |
| Source ID: | NCT00466713
|
| Associated Drug: |
Rosiglitazone Therapy
|
| Title: |
Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Dilated Cardiomyopathy
|
| Interventions: |
DRUG: Rosiglitazone therapy
|
| Outcome Measures: |
Primary: Myocardial glucose uptake (intrasubject before/after rosiglitazone)|Myocardial glucose uptake (between insulin-resistant & insulin-sensitive groups) | Secondary: Coronary flow-reserve|6-minute walk time
|
| Sponsor/Collaborators: |
Sponsor: Stanford University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
|
| Start Date: |
2007-03
|
| Completion Date: |
2007-12
|
| Results First Posted: |
|
| Last Update Posted: |
2014-05-13
|
| Locations: |
Stanford University Hospital, Stanford, California, 94305, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00466713
|
